{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:29:15Z","timestamp":1791340155203,"version":"4.3.1"},"reference-count":49,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,1,21]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Enrichment of atypical MPL mutations in essential thrombocythemia. MPLS204P and MPLY591N mutants are weak gain-of-function mutants.<\/jats:p>","DOI":"10.1182\/blood-2015-07-661983","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T23:04:29Z","timestamp":1444345469000},"page":"333-342","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":188,"title":["Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients"],"prefix":"10.1182","volume":"127","author":[{"given":"X\u00e9nia","family":"Cabagnols","sequence":"first","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, France;"},{"name":"Universit\u00e9 Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"UMR1170, Gustave Roussy, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizia","family":"Favale","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, France;"},{"name":"Universit\u00e9 Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"UMR1170, Gustave Roussy, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Pasquier","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, France;"},{"name":"Universit\u00e9 Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"UMR1170, Gustave Roussy, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahia","family":"Messaoudi","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, France;"},{"name":"Universit\u00e9 Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"UMR1170, Gustave Roussy, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Philippe","family":"Defour","sequence":"additional","affiliation":[{"name":"de Duve Institute, Universit\u00e9 Catholique de Louvain, Brussels, Belgium;"},{"name":"Ludwig Institute for Cancer Research, Signal Transduction & Molecular Hematology Unit, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Christophe","family":"Ianotto","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie, Centre Hospitalier Universitaire (CHU) Brest, Brest, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Marzac","sequence":"additional","affiliation":[{"name":"Laboratoire d\u2019H\u00e9matologie, H\u00f4pital Saint Antoine, Assistance Publique-H\u00f4pitaux de Paris, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Pierre","family":"Le Cou\u00e9dic","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, France;"},{"name":"Universit\u00e9 Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"UMR1170, Gustave Roussy, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Droin","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, France;"},{"name":"Universit\u00e9 Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"UMR1170, Gustave Roussy, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilyas","family":"Chachoua","sequence":"additional","affiliation":[{"name":"de Duve Institute, Universit\u00e9 Catholique de Louvain, Brussels, Belgium;"},{"name":"Ludwig Institute for Cancer Research, Signal Transduction & Molecular Hematology Unit, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Favier","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, France;"},{"name":"Universit\u00e9 Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"UMR1170, Gustave Roussy, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u2019boyba Khadija","family":"Diop","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, France;"},{"name":"Universit\u00e9 Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"UMR1170, Gustave Roussy, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Ugo","sequence":"additional","affiliation":[{"name":"Laboratoire d\u2019H\u00e9matologie, CHU Brest, Brest, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Casadevall","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, France;"},{"name":"Universit\u00e9 Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"Laboratoire d\u2019H\u00e9matologie, H\u00f4pital Saint Antoine, Assistance Publique-H\u00f4pitaux de Paris, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najet","family":"Debili","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, France;"},{"name":"Universit\u00e9 Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"UMR1170, Gustave Roussy, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Raslova","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, France;"},{"name":"Universit\u00e9 Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"UMR1170, Gustave Roussy, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bellann\u00e9-Chantelot","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, France;"},{"name":"Universit\u00e9 Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"D\u00e9partement de G\u00e9n\u00e9tique, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Universit\u00e9 Pierre et Marie Curie, Assistance Publique-H\u00f4pitaux de Paris, Paris, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan N.","family":"Constantinescu","sequence":"additional","affiliation":[{"name":"de Duve Institute, Universit\u00e9 Catholique de Louvain, Brussels, Belgium;"},{"name":"Ludwig Institute for Cancer Research, Signal Transduction & Molecular Hematology Unit, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bluteau","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, France;"},{"name":"Universit\u00e9 Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"UMR1170, Gustave Roussy, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Plo","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, France;"},{"name":"Universit\u00e9 Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"UMR1170, Gustave Roussy, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Vainchenker","sequence":"additional","affiliation":[{"name":"INSERM, Unit\u00e9 Mixte de Recherche (UMR) 1170, Gustave Roussy, Villejuif, France;"},{"name":"Universit\u00e9 Paris-Saclay, UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"UMR1170, Gustave Roussy, Villejuif, France;"},{"name":"Consultation d\u2019H\u00e9matologie-Immunologie, H\u00f4pital Saint Louis, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7","key":"2019111903255332600_B1","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/leu.2014.35","article-title":"An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms.","volume":"28","author":"Tefferi","year":"2014","journal-title":"Leukemia"},{"issue":"2","key":"2019111903255332600_B2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12185-010-0529-5","article-title":"Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria.","volume":"91","author":"Wadleigh","year":"2010","journal-title":"Int J Hematol"},{"issue":"4","key":"2019111903255332600_B3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.semcdb.2008.07.002","article-title":"JAKs in pathology: role of Janus kinases in hematopoietic malignancies and immunodeficiencies.","volume":"19","author":"Vainchenker","year":"2008","journal-title":"Semin Cell Dev Biol"},{"issue":"7","key":"2019111903255332600_B4","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.1211560110","article-title":"Tryptophan at the transmembrane-cytosolic junction modulates thrombopoietin receptor dimerization and activation.","volume":"110","author":"Defour","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"2019111903255332600_B5","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood-2008-04-149047","article-title":"The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarity.","volume":"114","author":"Ding","year":"2009","journal-title":"Blood"},{"issue":"11","key":"2019111903255332600_B6","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1182\/blood-2003-10-3471","article-title":"Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin.","volume":"103","author":"Ding","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2019111903255332600_B7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2008-01-131664","article-title":"MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort.","volume":"112","author":"Beer","year":"2008","journal-title":"Blood"},{"issue":"8","key":"2019111903255332600_B8","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/leu.2008.137","article-title":"New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1\/S-phase transition.","volume":"22","author":"Chalign\u00e9","year":"2008","journal-title":"Leukemia"},{"key":"2019111903255332600_B9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1756-8722-6-11","article-title":"Different mutations of the human c-mpl gene indicate distinct haematopoietic diseases.","volume":"6","author":"He","year":"2013","journal-title":"J Hematol Oncol"},{"issue":"11","key":"2019111903255332600_B10","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.exphem.2008.06.006","article-title":"Genetic profiling of myeloproliferative disorders by single-nucleotide polymorphism oligonucleotide microarray.","volume":"36","author":"Kawamata","year":"2008","journal-title":"Exp Hematol"},{"issue":"5","key":"2019111903255332600_B11","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ajh.23138","article-title":"A novel mutation in MPL (Y252H) results in increased thrombopoietin sensitivity in essential thrombocythemia.","volume":"87","author":"Lambert","year":"2012","journal-title":"Am J Hematol"},{"issue":"11","key":"2019111903255332600_B12","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.exphem.2007.08.010","article-title":"Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis.","volume":"35","author":"Williams","year":"2007","journal-title":"Exp Hematol"},{"issue":"6","key":"2019111903255332600_B13","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/bjh.12327","article-title":"SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.","volume":"161","author":"Koren-Michowitz","year":"2013","journal-title":"Br J Haematol"},{"issue":"6","key":"2019111903255332600_B14","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1182\/blood-2010-02-270108","article-title":"Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms.","volume":"116","author":"Oh","year":"2010","journal-title":"Blood"},{"issue":"25","key":"2019111903255332600_B15","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms.","volume":"369","author":"Klampfl","year":"2013","journal-title":"N Engl J Med"},{"issue":"25","key":"2019111903255332600_B16","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","article-title":"Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.","volume":"369","author":"Nangalia","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111903255332600_B17","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.biocel.2012.02.009","article-title":"Calreticulin signaling in health and disease.","volume":"44","author":"Wang","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"issue":"16","key":"2019111903255332600_B18","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood-2014-05-579136","article-title":"Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis.","volume":"124","author":"Tefferi","year":"2014","journal-title":"Blood"},{"issue":"7","key":"2019111903255332600_B19","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/leu.2014.3","article-title":"CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons.","volume":"28","author":"Tefferi","year":"2014","journal-title":"Leukemia"},{"issue":"4","key":"2019111903255332600_B20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.seminoncol.2005.04.011","article-title":"Myelofibrosis with myeloid metaplasia: diagnosis, prognostic factors, and staging.","volume":"32","author":"Cervantes","year":"2005","journal-title":"Semin Oncol"},{"issue":"4","key":"2019111903255332600_B21","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1046\/j.1365-2141.1999.01262.x","article-title":"The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia.","volume":"104","author":"Barosi","year":"1999","journal-title":"Br J Haematol"},{"issue":"7037","key":"2019111903255332600_B22","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"issue":"10","key":"2019111903255332600_B23","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1182\/blood-2007-05-089003","article-title":"Evidence for MPL W515L\/K mutations in hematopoietic stem cells in primitive myelofibrosis.","volume":"110","author":"Chalign\u00e9","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2019111903255332600_B24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/leu.2014.270","article-title":"Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution.","volume":"29","author":"Cabagnols","year":"2015","journal-title":"Leukemia"},{"issue":"10","key":"2019111903255332600_B25","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.3380","article-title":"Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.","volume":"47","author":"Saliba","year":"2015","journal-title":"Nat Genet"},{"issue":"9","key":"2019111903255332600_B26","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/2159-8290.CD-14-0104","article-title":"Acquired initiating mutations in early hematopoietic cells of CLL patients.","volume":"4","author":"Damm","year":"2014","journal-title":"Cancer Discov"},{"issue":"4","key":"2019111903255332600_B27","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood-2008-01-134114","article-title":"JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders.","volume":"112","author":"Plo","year":"2008","journal-title":"Blood"},{"issue":"2","key":"2019111903255332600_B28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/MCB.17.2.695","article-title":"A JAK1\/JAK2 chimera can sustain alpha and gamma interferon responses.","volume":"17","author":"Kohlhuber","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"49","key":"2019111903255332600_B29","doi-asserted-by":"crossref","first-page":"47954","DOI":"10.1074\/jbc.M205156200","article-title":"The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction.","volume":"277","author":"Saharinen","year":"2002","journal-title":"J Biol Chem"},{"issue":"42","key":"2019111903255332600_B30","doi-asserted-by":"crossref","first-page":"26208","DOI":"10.1016\/S0021-9258(18)47180-3","article-title":"Growth hormone specifically regulates serine protease inhibitor gene transcription via gamma-activated sequence-like DNA elements.","volume":"269","author":"Sliva","year":"1994","journal-title":"J Biol Chem"},{"issue":"9","key":"2019111903255332600_B31","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1182\/blood-2013-05-504555","article-title":"Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors.","volume":"123","author":"Marty","year":"2014","journal-title":"Blood"},{"issue":"12","key":"2019111903255332600_B32","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies.","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"issue":"8","key":"2019111903255332600_B33","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.celrep.2015.02.005","article-title":"Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis.","volume":"10","author":"McKerrell","year":"2015","journal-title":"Cell Reports"},{"issue":"26","key":"2019111903255332600_B34","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"2019111903255332600_B35","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes.","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111903255332600_B36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccr.2014.01.031","article-title":"Functional heterogeneity of genetically defined subclones in acute myeloid leukemia.","volume":"25","author":"Klco","year":"2014","journal-title":"Cancer Cell"},{"issue":"12","key":"2019111903255332600_B37","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/blood-2006-03-008805","article-title":"Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression.","volume":"108","author":"Moliterno","year":"2006","journal-title":"Blood"},{"key":"2019111903255332600_B38","article-title":"Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms.","author":"Milosevic Feenstra","journal-title":"Blood"},{"issue":"10","key":"2019111903255332600_B39","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/leu.2010.163","article-title":"LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations.","volume":"24","author":"Pardanani","year":"2010","journal-title":"Leukemia"},{"issue":"12","key":"2019111903255332600_B40","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1084\/jem.20011883","article-title":"Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice.","volume":"195","author":"Velazquez","year":"2002","journal-title":"J Exp Med"},{"key":"2019111903255332600_B41","author":"Vilaine"},{"issue":"31","key":"2019111903255332600_B42","doi-asserted-by":"crossref","first-page":"11444","DOI":"10.1073\/pnas.0404241101","article-title":"Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis.","volume":"101","author":"Moliterno","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2019111903255332600_B43","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1182\/blood-2007-11-124859","article-title":"Incomplete restoration of Mpl expression in the mpl-\/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.","volume":"113","author":"Lannutti","year":"2009","journal-title":"Blood"},{"issue":"14","key":"2019111903255332600_B44","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2014-03-560441","article-title":"Genetic studies reveal an unexpected negative regulatory role for Jak2 in thrombopoiesis.","volume":"124","author":"Meyer","year":"2014","journal-title":"Blood"},{"issue":"16","key":"2019111903255332600_B45","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1073\/pnas.1404354111","article-title":"Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.","volume":"111","author":"Ng","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2019111903255332600_B46","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood-2008-10-183558","article-title":"Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor.","volume":"115","author":"Pecquet","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2019111903255332600_B47","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1073\/pnas.94.6.2350","article-title":"Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain.","volume":"94","author":"Drachman","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2019111903255332600_B48","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.exphem.2014.02.007","article-title":"Phosphorylated c-Mpl tyrosine 591 regulates thrombopoietin-induced signaling.","volume":"42","author":"Sangkhae","year":"2014","journal-title":"Exp Hematol"},{"key":"2019111903255332600_B49","article-title":"Mutational profile of childhood myeloproliferative neoplasms [published online ahead of print July 30, 2015].","author":"Karow","journal-title":"Leukemia"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/3\/333\/1393530\/333.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/3\/333\/1393530\/333.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T18:29:20Z","timestamp":1653244160000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/127\/3\/333\/34889\/Presence-of-atypical-thrombopoietin-receptor-MPL"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,21]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,1,21]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-07-661983","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,21]]}}}